AlloVir (ALVR) News Today $2.61 +0.18 (+7.41%) As of 07/14/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Kalaris Announces Closing of Merger with AlloVirMarch 18, 2025 | globenewswire.comAlloVir shareholders approve merger with Kalaris TherapeuticsMarch 14, 2025 | investing.comAlloVir, Inc.: Kalaris and AlloVir Announce Stockholder Approval of MergerMarch 13, 2025 | finanznachrichten.deKalaris, AlloVir announce stockholder approval of mergerMarch 13, 2025 | markets.businessinsider.comKalaris and AlloVir Announce Stockholder Approval of MergerMarch 12, 2025 | globenewswire.comAlloVir, Inc. (ALVR) Latest Press Releases & Corporate News - Yahoo FinanceMarch 4, 2025 | finance.yahoo.comAllovir's Vikas Sinha sells shares worth $3,052February 26, 2025 | investing.comAllovir's chief accounting officer sells $967 in stockFebruary 26, 2025 | investing.comAlloVir, Inc. (NASDAQ:ALVR) Short Interest UpdateFebruary 17, 2025 | marketbeat.comAlloVir (NASDAQ:ALVR) Stock Price Up 0.5% - Should You Buy?February 8, 2025 | marketbeat.comAllovir's general counsel sells $494 in stockJanuary 28, 2025 | msn.comAllovir director Vikas Sinha sells $1,225 in stockJanuary 27, 2025 | msn.comAllovir's chief accounting officer sells $342 in common stockJanuary 27, 2025 | msn.comAlloVir (NASDAQ:ALVR) Trading 8.2% Higher - Here's What HappenedJanuary 17, 2025 | marketbeat.comAlloVir trading halted, news pendingJanuary 16, 2025 | markets.businessinsider.comAlloVir (NASDAQ:ALVR) Hits New 1-Year Low - Should You Sell?January 16, 2025 | marketbeat.com$TOCKHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - AVTE, BCOV, ALVR, AEDecember 21, 2024 | markets.businessinsider.comAlloVir Appoints Vikas Sinha as New CEODecember 20, 2024 | tipranks.comShort Interest in AlloVir, Inc. (NASDAQ:ALVR) Increases By 57.4%December 12, 2024 | marketbeat.comAlloVir (NASDAQ:ALVR) Trading Down 1.2% - Time to Sell?December 12, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Sees Significant Drop in Short InterestNovember 15, 2024 | marketbeat.com$hareholder Alert: The M&A Class Action Firm Continues to Investigate the Merger of ROIC, VINE, ALVR and CDMONovember 13, 2024 | stockhouse.comALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVRNovember 9, 2024 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of ShareholdersNovember 9, 2024 | globenewswire.comAlloVir (NASDAQ:ALVR) Stock, Option ChainNovember 9, 2024 | benzinga.comAlloVir and Kalaris Merge to Advance Retinal TherapiesNovember 9, 2024 | markets.businessinsider.comAlloVir falls after all-stock merger deal with KalarisNovember 9, 2024 | msn.comAlloVir to combine with Kalaris Therapeutics in all-stock transactionNovember 9, 2024 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of ShareholdersNovember 8, 2024 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of AlloVir, Inc. – ALVRNovember 8, 2024 | globenewswire.comALVR Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of AlloVir, Inc. Is Fair to ShareholdersNovember 8, 2024 | businesswire.comShareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public ShareholdersNovember 8, 2024 | businesswire.comAlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the RetinaNovember 8, 2024 | globenewswire.comDiscovering Opportunities: AlloVir And 2 Other US Penny StocksOctober 31, 2024 | finance.yahoo.comWasatch Small Cap Growth InstitutionalOctober 16, 2024 | morningstar.comMOctagon Capital Advisors LP Increases Stake in AlloVir IncOctober 12, 2024 | finance.yahoo.comWasatch Small Cap Growth InvestorSeptember 28, 2024 | morningstar.comMAlloVir (NASDAQ:ALVR) Shares Up 1%September 17, 2024 | marketbeat.comKuehn Law Encourages Investors of AlloVir, Inc. to Contact Law FirmSeptember 16, 2024 | globenewswire.comMaintaining Hold on AlloVir Amid Financial Performance and Strategic UncertaintyAugust 13, 2024 | markets.businessinsider.comAlloVir (NASDAQ:ALVR) Stock Quotes, Forecast and News SummaryAugust 8, 2024 | benzinga.comHere's Why AlloVir (NASDAQ:ALVR) Must Use Its Cash WiselyJuly 31, 2024 | finance.yahoo.comAcadian Asset Management LLC Has $1.20 Million Stake in AlloVir, Inc. (NASDAQ:ALVR)July 26, 2024 | marketbeat.comAlloVir (NASDAQ:ALVR) Trading Up 3.3%July 9, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Shares Sold by Wasatch Advisors LPJune 12, 2024 | marketbeat.comQ2 2024 EPS Estimates for AlloVir, Inc. (NASDAQ:ALVR) Cut by AnalystMay 16, 2024 | marketbeat.comALVR Stock Earnings: AlloVir Misses EPS for Q1 2024May 14, 2024 | investorplace.comAlloVir, Inc. (ALVR)May 1, 2024 | finance.yahoo.comShort Interest in AlloVir, Inc. (NASDAQ:ALVR) Rises By 5.7%April 2, 2024 | marketbeat.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 20, 2024 | stockhouse.com Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address ALVR Media Mentions By Week ALVR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVR News Sentiment▼0.000.99▲Average Medical News Sentiment ALVR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVR Articles This Week▼01▲ALVR Articles Average Week Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RNXT News RENB News ZIVO News QNTM News CRVO News AADI News BLUE News OSTX News VTVT News DTIL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVR) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AlloVir With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALVR Stock Alerts